Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- ABSI
- Price
- 4.35
- Stock movement up
- +0.65 (17.57%)
- Company name
- Absci Corp
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 499.62M
- Ent value
- 495.32M
- Price/Sales
- 118.76
- Price/Book
- 2.48
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -1.14%
- 3 year return
- -11.43%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-02-04
iO Charts is a Seeking Alpha partner
Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I think ABSI stock is a good buy.
January 13, 2025
iO Charts is a Seeking Alpha partner
DIVIDENDS
ABSI does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 118.76 |
| Price to Book | 2.48 |
| EV to Sales | 117.74 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 114.86M |
| EPS (TTM) | -0.86 |
| FCF per share (TTM) | -0.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.21M |
| Gross profit (TTM) | -6.08M |
| Operating income (TTM) | -103.35M |
| Net income (TTM) | -97.67M |
| EPS (TTM) | -0.86 |
| EPS (1y forward) | -0.74 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -144.45% |
| Operating margin (TTM) | -2456.69% |
| Profit margin (TTM) | -2321.56% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 38.20M |
| Net receivables | 1.50M |
| Total current assets | 150.14M |
| Goodwill | 0.00 |
| Intangible assets | 45.73M |
| Property, plant and equipment | 0.00 |
| Total assets | 235.23M |
| Accounts payable | 1.67M |
| Short/Current long term debt | 11.99M |
| Total current liabilities | 26.69M |
| Total liabilities | 33.90M |
| Shareholder's equity | 201.34M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -70.36M |
| Capital expenditures (TTM) | 398.00K |
| Free cash flow (TTM) | -70.76M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -48.51% |
| Return on Assets | -41.52% |
| Return on Invested Capital | -47.34% |
| Cash Return on Invested Capital | -34.29% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.70 |
| Daily high | 4.38 |
| Daily low | 3.65 |
| Daily Volume | 12.4M |
| All-time high | 30.29 |
| 1y analyst estimate | 8.38 |
| Beta | 2.19 |
| EPS (TTM) | -0.86 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 19 Mar 2025 |
Downside potential
Loading...
Downside potential data
| ABSI | S&P500 | |
| Current price drop from All-time high | -85.64% | -1.31% |
| Highest price drop | -96.20% | -56.47% |
| Date of highest drop | 26 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -83.23% | -11.10% |
| Avg time to new high | 148 days | 12 days |
| Max time to new high | 881 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
499.62M
Marketcap category
Small-cap
Description
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Employees
155
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Absci Corporation (NASDAQ:ABSI) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ETCompany ParticipantsAlex Khan - VP, Finance and IRSean McClain -...
August 17, 2024
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page